Subtalar Extra-articular Screw Arthroereisis

April 29, 2024 updated by: Professor Giacomo Placella, Università Vita-Salute San Raffaele

Subtalar Extra-articular Screw Arthroereisis: How Does the Screw Work

The aim of the study is to investigate the effect of subtalar extra-articular calcaneo-stop screw on the proprioceptive and nociceptive pathways of the ankle before and after implantation. The hypothesis of the study is that an increased number of receptors related to proprioception will be detected in the sinus tarsi.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lombardy
      • Milan, Lombardy, Italy, 20149
        • IRCSS Ospedale San Raffaele

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patients with subtalar extraarticular screw arthroereisis, gender male and female, no comorbidities.

Control group are patients that will insert the calcaneo-stop screw (age between 10 and 14 years old).

Study group are patient that remove the calcaneo-stop screw (age from 14 years old)

Description

Inclusion Criteria:

Study Group:

  • Patients aged 14 years old and above that will remove the calcaneo stop screw, in place for at least 3 years after the implant, will be recruited
  • Patients willing and able to give informed consent for the participation in the study. For underage patients, a parent/legal representative will give consent for the participation in the study.
  • Male and female patients in fertile age can be recruited.

Control Group:

  • Syndromic patients
  • Previous foot malformation (synostosis, congenital clubfoot)
  • Female participant who is pregnant, lactating or planning pregnancy during the course of the study.

Exclusion Criteria:

Control Group:

  • Syndromic patients
  • Previous foot malformation (synostosis, congenital clubfoot)
  • Female participant who is pregnant, lactating or planning pregnancy during the course of the study.

Study Group:

  • Patients suffering from post-operative complications
  • Syndromic patients
  • Previous foot malformation (synostosis, congenital clubfoot)
  • Female participant who is pregnant, lactating or planning pregnancy during the course of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control Group
Control group are patients that will insert the calcaneo-stop screw (age between 10 and 14 years old).
For the study, a minimal part of the periarticular tissue, specifically the sinus tarsi juxta-articular fatty tissue, that is normally dissected and discarded during the surgical operation of insertion and removal of the calcaneo-stop screw, will be analyzed
Study Group
Study group are patient that remove the calcaneo-stop screw (age from 14 years old)
For the study, a minimal part of the periarticular tissue, specifically the sinus tarsi juxta-articular fatty tissue, that is normally dissected and discarded during the surgical operation of insertion and removal of the calcaneo-stop screw, will be analyzed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary Endpoint (%)
Time Frame: Time 0 (baseline)
Percentage of patients presenting at least one proprioceptive fibers in the pericapsular tissue
Time 0 (baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Secondary Endpoint
Time Frame: Time 0 (baseline)
Number and type of nervous fibers
Time 0 (baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

May 1, 2025

Study Completion (Estimated)

May 1, 2025

Study Registration Dates

First Submitted

April 24, 2024

First Submitted That Met QC Criteria

April 26, 2024

First Posted (Actual)

April 29, 2024

Study Record Updates

Last Update Posted (Actual)

May 1, 2024

Last Update Submitted That Met QC Criteria

April 29, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Flatfoot, Flexible

Clinical Trials on Histological Analysis

Subscribe